Asperosaponin-VI induces osteoblast differentiation through BMP-2/p38 and ERK1/2 pathway. Asperosaponin VI inhibits apoptosis in hypoxia-induced cardiomyocyte by increasing the Bcl-2/Bax ratio and decreasing active caspase-3 expression, as well as enhancing of p-Akt and p-CREB.
Molecular Weight:
929.1
Purity:
>98.5%
CAS Number:
[39524-08-8]
Formula:
C47H76O18
Target:
Caspase
* VAT and and shipping costs not included. Errors and price changes excepted